Evidence map›Paper›PMID 39858035›Full record

ArticleCancers2025

γδ T Are Significantly Impacted by CLL Burden but Only Mildly Influenced by M-MDSCs.

Michał Zarobkiewicz, Wioleta Kowalska, Agata Szymańska, Natalia Lehman, Bożena Kowalczyk, Waldemar Tomczak, Agnieszka Bojarska-Junak

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michał ZarobkiewiczDepartment of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0003-0788-6353
Wioleta KowalskaDepartment of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0003-0930-5874
Agata SzymańskaDepartment of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0002-3764-7452
Natalia LehmanDepartment of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0003-2324-5679
Bożena KowalczykDepartment of Genetics and Microbiology, Maria Curie-Sklodowska University, 20-033 Lublin, Poland.
Waldemar TomczakDepartment of Haematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-080 Lublin, Poland.
Agnieszka Bojarska-JunakDepartment of Clinical Immunology, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0003-2340-9442

Funding

National Science Center Preludium grant number 2019/35/N/NZ6/02973
6 · The paper itself

Abstract

BACKGROUND/

objectivesThe current study explores the impact of CLL on γδ T cells and, in an attempt to better understand the sources of immunosuppression, assesses the impact of M-MDSCs on γδ T cells in vitro.

methodsThe study included 163 CLL patients and 34 healthy volunteers. γδ T cells were screened with flow cytometry, including NKG2D, Fas, FasL, and TRAIL staining. Additionally, to deepen understanding of the immunosuppressive impact of CLL on γδ T, a set of in vitro co-cultures of γδ T and M-MDSCs was performed.

resultsRNAseq revealed significant, though relatively minor, changes in the transcriptome. Functional analyses showed a minor drop in cytotoxic potential against CLL cells. Finally, depletion of M-MDSCs from CLL-derived peripheral blood mononuclear cells did not restore γδ T cells' proliferative response.

conclusionsAltogether, this suggests a minor impact of M-MDSCs on activated γδ T. Thus, it seems probable that other mechanisms than M-MDSCs mediate the negative impact of CLL on circulating γδ T cells.

Indexed as

chronic lymphocytic leukaemia (CLL)gamma delta TimmunosuppressionM-MDSCγδ T

Identifiers

PMID39858035
PMCPMC11763719

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.